Skin appendage disorder
MONDO:0024481A disease that involves the cutaneous appendage.
Also known as: cutaneous appendage disease, cutaneous appendage disease or disorder, disease of cutaneous appendage, disease or disorder of cutaneous appendage, disorder of cutaneous appendage, disorder of skin appendage, disease of epidermal appendage, disease of epidermal appendages
244 clinical trials for this condition and its sub-types, 0 tagged with Skin appendage disorder itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Skin appendage disorder
-
Hair anomaly 0 trials · 228 incl. sub-types
8 sub-types
- Alopecia 130 trials · 225 incl. sub-types Sub-types →
- Pili bifurcati 2 trials
- Ringed hair disease 1 trial
- Isolated familial wooly hair disorder 0 trials Sub-types →
- Pili gemini 0 trials
- Pili torti 0 trials
- Trichodysplasia-xeroderma syndrome 0 trials
- Uncombable hair syndrome 0 trials Sub-types →
-
Epidermal appendage tumor 3 trials · 8 incl. sub-types
5 sub-types
- Skin appendage carcinoma 4 trials · 6 incl. sub-types Sub-types →
- Sebaceous gland neoplasm 0 trials · 3 incl. sub-types Sub-types →
- Sweat gland neoplasm 0 trials · 3 incl. sub-types Sub-types →
- Hair follicle neoplasm 0 trials Sub-types →
- Hamartoma of skin appendage 0 trials Sub-types →
-
Internal hordeolum 1 trial · 6 incl. sub-types
1 sub-type
- Chalazion 5 trials
-
Piedra 0 trials · 2 incl. sub-types
3 sub-types
- White piedra 2 trials
- Black piedra 0 trials
- Endothrix infectious disease 0 trials
Most studied deeper sub-types
-
New drug aimed at regrowing hair in severe alopecia
Disease control Stopped earlyThis study tested a drug called amlitelimab in 166 adults with severe alopecia areata, a condition causing significant hair loss. Participants received either the drug or a placebo by injection. The main goal was to see if the drug could reduce hair loss scores after 36 weeks. Th…
Phase 2 • Sponsor: Sanofi • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
Exosome hair loss study halted early – what we know
Disease control Stopped earlyThis study tested whether exosomes from donated stem cells could help people with hair loss. It was a small, early-phase trial with 16 participants, comparing treated areas to untreated ones. The study was terminated early, so results are limited. The goal was to see if the treat…
Early phase 1 • Sponsor: Guangzhou Bio-gene Technology Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 12:39 UTC
-
New pill shows promise for severe baldness, but trial cut short
Disease control Stopped earlyThis study tested a drug called KL130008 in 114 adults with severe alopecia areata, a condition causing major hair loss. The goal was to see if the drug could safely regrow hair, measured by how many people achieved 80% or more scalp coverage. However, the trial was terminated ea…
Phase 2 • Sponsor: Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
Hair loss ointment study halted early – only 4 people enrolled
Disease control Stopped earlyThis study tested a custom ointment called DPCP to help people with severe alopecia areata, a condition causing patchy or complete scalp hair loss. The goal was to see if the ointment could safely regrow hair. Only 4 people took part before the study was stopped early, so results…
Phase 3 • Sponsor: University of Minnesota • Aim: Disease control
Last updated Jun 27, 2026 08:14 UTC
-
Light therapy for stubborn eyelid lumps? tiny trial ends early
Disease control Stopped earlyThis study tested whether intense pulsed light (IPL) can help treat chalazion, a common eyelid lump. Only 4 adults with a fresh chalazion were enrolled, and the trial was stopped early. Because of the very small size, we cannot say if IPL works or is safe for this condition.
Sponsor: Lumenis Be Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
Gut bacteria supplement tested against chemo hair loss
Symptom relief Stopped earlyResearchers are testing a synbiotic formula called BLHK03 to see if it can reduce hair loss caused by chemotherapy in women with breast cancer. The trial includes 7 women with stage I to III breast cancer who are scheduled for chemotherapy with anthracycline or taxane drugs. Part…
Sponsor: GenieBiome Limited • Aim: Symptom relief
Last updated Sep 20, 2026 00:00 UTC
-
WaterPik for your head? study tests scalp massager for flakes and hair loss
Symptom relief Stopped earlyThis study tested a WaterPik-like device to massage and clean the scalp in people with dandruff, seborrheic dermatitis, or hair loss. Only 2 people took part before the study was stopped early. The goal was to see if the device could reduce flaking and redness.
Sponsor: University of Minnesota • Aim: Symptom relief
Last updated Sep 06, 2026 00:00 UTC
-
Can a laser make hair grow? small study tests skin rejuvenation for bald spots
Symptom relief Stopped earlyThis study tested whether a laser treatment used for skin rejuvenation could help grow hair in people with alopecia (hair loss) on the scalp. Only 5 people were enrolled before the study was stopped early. Each person had half their scalp treated with a laser and the other half l…
Sponsor: University of California, Irvine • Aim: Symptom relief
Last updated Jun 27, 2026 09:09 UTC
-
Hair loss hope? supplement tested in men, but study stopped early
Symptom relief Stopped earlyThis study tested a dietary supplement made from plant extracts to see if it could help men aged 40 to 65 with thinning hair. The trial was planned to last 9 months and involved 155 men, but it was terminated early. Researchers aimed to measure hair growth and quality compared to…
Sponsor: Nutraceutical Wellness Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 08:01 UTC